Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2008
03/11/2008CA2180856C Porous particle aggregate and method therefor
03/07/2008CA2599849A1 Synthetic platelets
03/06/2008WO2008028193A2 Colon-targeted oral formulations of cytidine analogs
03/06/2008WO2008028047A2 Bioadhesive film drug delivery system
03/06/2008WO2008027993A2 Drug delivery systems comprising solid solutions of weakly basic drugs
03/06/2008WO2008027963A2 Nsaid dose unit formulations with h2-receptor antagonists and methods of use
03/06/2008WO2008027945A1 Extended release gastro-retentive oral drug delivery system for valsartan
03/06/2008WO2008027793A2 Ophthalmic pharmaceutical compositions and uses thereof
03/06/2008WO2008027611A2 Compositions for visualization of vitreous body and methods of using same
03/06/2008WO2008027600A2 Imatinib compositions
03/06/2008WO2008027557A2 Topiramate compositions and methods of enhancing its bioavailability
03/06/2008WO2008027532A2 Pharmaceutical compositions including vitamin d and corticosteroid
03/06/2008WO2008027442A2 Abuse deterrent oral pharmaceutical formulations of opioid agonists and method of use
03/06/2008WO2008027350A2 Acetaminophen pharmaceutical compositions
03/06/2008WO2008027218A2 Drug electrotransport with hydration measurement of hydratable reservoir
03/06/2008WO2008027203A2 Medicated orthopedic support structures for treatment of damaged musculoskeletal tissue
03/06/2008WO2008026984A1 Topical composition comprising a dihydropyridine calcium antagonist
03/06/2008WO2008026962A1 Agent for treating eye diseases
03/06/2008WO2008026894A1 Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby
03/06/2008WO2008026785A1 Lipid metabolism improving agent containing hydrogen molecule
03/06/2008WO2008026781A1 Reverse targeting lipid vesicle
03/06/2008WO2008026776A1 Transdermal composition, transdermal pharmaceutical composition and transdermal cosmetic composition comprising polymer micelle encapsulating active ingredient
03/06/2008WO2008026765A2 Lyophilized preparation
03/06/2008WO2008026756A1 Ophthalmic percutaneous absorption type preparation
03/06/2008WO2008026702A1 Pharmaceutical composition containing statin-encapsulated nanoparticle
03/06/2008WO2008026644A1 Hydrophilic matrix having poorly water-soluble compound sealed therein, and method for producing the same
03/06/2008WO2008026556A1 Freeze-dried preparation of 1-methylcarbapenem
03/06/2008WO2008026381A1 Nail patch
03/06/2008WO2008026310A1 Protective agent for oral mucosa containing trehalose
03/06/2008WO2008025837A1 Improvements in pharmaceutical compositions
03/06/2008WO2008025791A1 Buprenophine-wafer for drug substitution therapy
03/06/2008WO2008025784A1 Food protein and charged emulsifier interaction
03/06/2008WO2008025773A1 Pharmaceutical compositions comprising cefquinome
03/06/2008WO2008025563A2 Polymer matrix, method for its production, and its use
03/06/2008WO2008025560A1 Methods for taste masking of nebulised compositions for nasal and pulmonary inhalation therapy
03/06/2008WO2008025535A1 Controlled release oral dosage formulations comprising a core and one or more barrier layers
03/06/2008WO2008025532A1 Controlled release solid oral dosage formulations comprising nisoldipine
03/06/2008WO2008025425A1 Microparticles based on an amphiphilic copolymer and on active ingredient(s) with modified release and pharmaceutical formulations containing same
03/06/2008WO2008025380A1 Medicament containing fluoroquinolones
03/06/2008WO2008025228A1 The antibiotics composition comprising beta-lactam antibiotics and buffers
03/06/2008WO2008025227A1 The antibiotics composition comprising aminoglycoside antibiotics
03/06/2008WO2008025226A1 The antibiotics composition comprising beta-lactam antibiotics and ionic chelating agents
03/06/2008WO2008025111A2 Biodegradable device for intraocular drug delivery
03/06/2008WO2008011595A9 Hydrophobic abuse deterrent delivery system
03/06/2008WO2008011177A3 Medicinal delivery system and related methods
03/06/2008WO2008010788A9 Compositions and methods for making and using nanoemulsions
03/06/2008WO2008008595A3 Use of a chewing gum in a method of reducing infection
03/06/2008WO2008007152A3 Preparation of pharmaceutical formulations
03/06/2008WO2008007151A3 Processes for preparing pharmaceutical compositions
03/06/2008WO2008005534A3 Orally dissolving formulations of memantine
03/06/2008WO2008000463A3 Rabeprazole formulation
03/06/2008WO2007142951A3 Oral controlled release formulations of an interleukin-1 beta converting enzyme inihibitor
03/06/2008WO2007135461A3 Pharmaceutical compositions comprising implitapide and methods of using same
03/06/2008WO2007126993A3 Multi-membrane immunoisolation system for cellular transplant
03/06/2008WO2007121913A3 Pharmaceutical solution formulations for pressurised metered dose inhalers
03/06/2008WO2007111933A3 Pharmaceutical compositions comprising a hypoglycemic agent and methods of using same
03/06/2008WO2007085946A3 Novel cosmetic and dermatological compositions based on algae extracts
03/06/2008WO2007078874A3 Oral pharmaceutical formulations containing non-steroidal anti-inflammatory drugs and acid inhibitors
03/06/2008WO2007058923A3 Composition of fentanyl citrate oral solid transmucosal dosage form, dextrose monohydrate as major excipient and binding material therefor and methods of producing them
03/06/2008WO2007041156A3 Antibiotic formulations, unit doses, kits, and methods
03/06/2008WO2007039825A3 Saccharide foamable compositions
03/06/2008WO2007006885A8 Method for producing a powder containing xylitol crystal particles with another polyol
03/06/2008WO2006125819A3 Oral microparticulate, anti-misuse drug formulation
03/06/2008WO1999045887A3 Monolithic tablet for controlled drug release
03/06/2008US20080058898 Implantable Retinal Electrode Array Configuration for Minimal Retinal Damage and Method of Reducing Retinal Stress
03/06/2008US20080058772 Personal paramedic
03/06/2008US20080058771 Method for Multiple Dosage of Liquid Products, Dosing Apparatus and Dosing System
03/06/2008US20080058760 Use Of A Viscoelastic Composition For Treating Increased Intraocular Pressure
03/06/2008US20080058733 Antibiotic(s)-polymer combination
03/06/2008US20080058689 Phototherapy bandage
03/06/2008US20080058502 Method for preparing microparticles having a selected polymer molecular weight
03/06/2008US20080058424 Novel pharmaceutical formulations of modafinil
03/06/2008US20080058404 Co-milling ramipril with lubricant selected from glyceryl behenate, polyethylene glycol, stearic acid, sodium stearyl fumarate, and combinations thereof; cardiovascular disorders; hypertension
03/06/2008US20080058403 Administering photoactive porphyrin, and awaiting localization in ocular tissue; radiating with laser light; macular degeneration; neovascularization
03/06/2008US20080058363 Pharmaceutical composition for treating fecal incontinence and anal itch
03/06/2008US20080058296 Formulations and methods for treating rhinosinusitis
03/06/2008US20080058295 Nasal pharmaceutical formulations and methods of using the same
03/06/2008US20080058292 Administering synergistic mixture of adipocyte proteinG antagonist and peroxisome proliferator activator antagonist; concurrent administering niacin and non-steroid antiinflammatory drug
03/06/2008US20080058270 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
03/06/2008US20080058249 Complexes
03/06/2008US20080057136 An ionogenic surfactant, a metal chelating complex with an affinity for protons, solvent and carrier; preferably cetylpyridinium chloride, EDTA-zinc complex, and isopropanol; fungicides for oral, topical or intravenous administration; dandruff, acne, dermatitis
03/06/2008US20080057133 Preparation of Aqueous Clear Solution Dosage Forms with Bile Acids
03/06/2008US20080057131 Glycolic acid-lactic acid copolymer matrix incorporated with a peptide drug and a corticosteroid; sustained release for two weeks; improved bioavailability
03/06/2008US20080057130 The surface treatment of nanoparticles to control interfacial properties and method of manufacture
03/06/2008US20080057129 Deposited by sublimation onto a carrier chosen from lactose, dextran, dextrose, and mannitol, and are suitable for administration by inhalation or injection; lung infections in patients with cystic fibrosis; calcitrol, azithromycin; improved bioavailability
03/06/2008US20080057128 Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
03/06/2008US20080057127 Functionalized non-phenolic amino acids and absorbable polymers therefrom
03/06/2008US20080057126 Implant and process for its production
03/06/2008US20080057125 Amorphous sodium salt of a benzimidazole PPI produced in situ, coated on hydroxypropyl methyl cellulose granulated and pelletized powder and covered with a sub-coating and an outer enteric coating; improved bioavailability and acidic stability, side effect reduction, lower dosages
03/06/2008US20080057124 Indolyl-3-glyoxylic acid derivatives having therapeutically valuable properties
03/06/2008US20080057123 Tablet core has the drug and an enteric material and is surrounded by one or more barrier layers of swellable, erodible, or gellable polymers; release rate increases in resopnse to increasing pH as the tablet descends the gastrointestinal tract; once daily dosing
03/06/2008US20080057122 Acetaminophen pharmaceutical compositions
03/06/2008US20080057121 Pharmaceutical Composition and Galenic Form Corresponding to Rapid Oral Disintegration and Method for Production of Said Composition
03/06/2008US20080057120 controlled release tablet of bupropion hydrobromide for reducing the ratio of the maximum/minimum plasma bupropion hydrobromide concentration (Cmax/Cmin) while maintaining bupropion plasma levels within the therapeutic window upon administration to a patient; more stable than buproin hcl
03/06/2008US20080057119 low dosage of zolpidem, or zolpidem hemitartrate when formulated for delivery across the oral mucosa, can induce rapid onset of sleep without residual sedative effects upon awakening 2-4 hours late
03/06/2008US20080057118 Divalproex pharmaceutical compositions
03/06/2008US20080057117 Pharmaceutical composition made up of cannibus extracts
03/06/2008US20080057116 Emu Oil and Fruit Composition
03/06/2008US20080057115 2-propyloctanoic acid for treating neurodegenerative diseses contained in a capsule, internally taken safely without feeling acidness, pain, burning sensation in the oral cavity, dissoved quickly in stomach without delay; shell comprises gelatin, sacchride as base and glycerine as plasticizer, a fat
03/06/2008US20080057114 Sinker capsules
1 ... 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 ... 2991